Implementing hospital-based baby boomer hepatitis c virus screening and linkage to care: Strategies, results, and costs

Journal of Hospital Medicine

Volumn 10, Issue 8, 2015, Pages 510-516

  Turner, Barbara J ^a   Taylor, Barbara S ^a   Hanson, Joshua T ^a   Perez, Mary Elizabeth ^a   Hernandez, Ludivina ^a   Villarreal, Roberto ^b   Veerapaneni, Poornachand ^a   Fiebelkorn, Kristin ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY HEALTH SYSTEM   (United States)

^c University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ALCOHOLISM; ARTICLE; COHORT ANALYSIS; COMPUTERIZED PROVIDER ORDER ENTRY; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE COST; HEPATITIS C; HOMELESSNESS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL EDUCATION; MEDICALLY UNINSURED; MIDDLE AGED; PATIENT CARE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; STAFF TRAINING; UNITED STATES; ECONOMICS; HOSPITAL COST; HOSPITALIZATION; PILOT STUDY; POPULATION GROWTH; PROCEDURES;

COHORT STUDIES; FEMALE; HEPATITIS C; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT CARE; PILOT PROJECTS; POPULATION GROWTH; PROSPECTIVE STUDIES;

EID: 84938211526     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.2376     Document Type: Article

References (34)

1. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61:1-32.
2. 2. Centers for Disease Control and Prevention. Vital signs: evaluation of hepatitis C virus infection testing and reporting-eight U.S. sites, 2005-2011. MMWR Morb Mortal Wkly Rep. 2013;62:357-361.
3. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int. 2011;31:1090-1101.
4. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: The National Academies Press; 2010.
5. Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013;368:1907-1917.
6. Kanwal F, Hoang T, Kramer JR, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011;140:1182-1188.
7. U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:349-357.
8. Brady KA, Weiner MJ, Turner BJ. Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals. J Infect. 2009;59:62-69.
9. U.S. Preventive Services Task Force. Screening for HIV: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:51-60.
10. Berkenblit GV, Sosman JM, Bass M, et al. Factors affecting clinician educator encouragement of routine HIV testing among trainees. J Gen Intern Med. 2012;27:839-844.
11. Walensky RP, Reichmann WM, Arbelaez C, et al. Counselor-versus provider-based HIV screening in the emergency department: Results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial. Ann Emerg Med. 2011;58:S126-S132.e1-4.
12. Greenwald JL, Hall J, Skolnik PR. Approaching the CDC's guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testing. AIDS Patient Care STDS. 2006;20:311-317.
13. Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013;62:362-365.
14. Advia Centaur Assay Manual. Malvern, PA: Siemens Medical Solutions Diagnostics; Pub# 07063235, Rev. C, 2005-01.
15. Taylor P, Pickard G, Gammie A, Atkins M. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J Clin Virol. 2004;30:S11-S15.
16. National Institute on Alcohol Abuse and Alcoholism. Drinking levels defined. Available at: http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed June 12, 2014.
17. Galbraith JW, Franco RA, Donnelly JP, et al. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology. 2015;61:776-782.
18. Hoover KW, Butler M, Workowski KA, et al. Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis. 2012;39:349-353.
19. Ditah I, Ditah F, Devaki P, Ditah C, Kamath PS, Charlton M. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol. 2014;60:691-698.
20. Rongey CA, Kanwal, Hoang T, Gifford AL, Asch SM. Viral RNA testing in hepatitis C antibody-positive veterans. Am J Prev Med. 2009;36:235-238.
21. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293-300.
22. Busch MP, Glynn SA, Stramer SL, et al. NHLBI Retrovirus Epidemiology Donor Study (REDS) Group. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion. 2006;46:469-475.
23. Rolfe KJ, Curran MD, Alexander GJ, Wodall T, Andrews N, Harris HE. Spontaneous loss of hepatitis C virus RNA from serum is associated with genotype 1 and younger age at exposure. J Med Virol. 2011;83:1338-1344.
24. Grebely J, Dore GJ, Kim AY, et al. Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn. Hepatology. 2014;60:2127-2128.
25. Fitch K, Iwasaki K, Pyenson B, Engel T. Health care reform and hepatitis C: a convergence of risk and opportunity. Available at: http://us.milliman.com/uploadedFiles/insight/2013/convergence-of-risk-and-opportunity.pdf. Accessed February 5, 2015.
26. Tohme RA, Xing J, Liao Y, Holmberg SD. Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010. Am J Public Health. 2013;103:112-119.
27. McGowan CE, Fried MW. Barriers to hepatitis C treatment. Liver Int. 2012;32:151-156.
28. Younossi ZM, Zheng L, Stepanova M, Venkatesan C, Mir HM. Moderate, excessive or heavy alcohol consumption: Each is significantly associated with increased mortality in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2013;37:703-709.
29. Centers for Medicare and Medicaid Services. Proposed decision memo for screening for hepatitis c virus (HCV) in adults (CAG-00436N). Available at: http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=272. Accessed June 2, 2014.
30. Hoofnagle JH, Sherker AH. Therapy for hepatitis C-the costs of success. N Engl J Med. 2014;370:1552-1553.
31. McGarry LJ, Pawar VS, Panchmatia HR, et al. Economic model of a birth cohort screening program for hepatitis C. Hepatology. 2012;55:1344-1355.
32. Liu S, Cipriano LE, Holodniy M, Goldhaber-Fiebert JD. Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS One. 2013;8:e58975.
33. Rein DB, Smith BD, Wittenborn JS, et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012;156:263-270.
34. U.S. Department of Health and Human Services. Health Resources and Services Administration: HIV/AIDS programs. Available at: http://hab.hrsa.gov/abouthab/legislation.html. Accessed April 8, 2015.